L. Cominacini et al., Comparative effects of different dihydropyridines on the expression of adhesion molecules induced by TNF-alpha on endothelial cells, J HYPERTENS, 17(12), 1999, pp. 1837-1841
Citations number
42
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
Objective Lacidipine has already been demonstrated to reduce the expression
of some adhesion molecules induced by pro-oxidant signals on endothelial c
ells. In order to verify if this effect is a peculiarity of this molecule,
or belongs to other dihydropyridinic compounds (DHPs), the activity of laci
dipine was compared with that of lercanidipine, amlodipine, nimodipine and
nifedipine.
Design and methods The compounds were incorporated in human umbilical vein
endothelial cells (HUVECs) using native low-density lipoprotein as a carrie
r. The drug concentrations in HUVECs were measured by mass spectrometry. Hu
man recombinant tumour necrosis factor-alpha was then incubated with HUVECs
for 7 h at 37 degrees C for adhesion molecule expression.
Results The cellular amount of lacidipine, lercanidipine and amlodipine was
similar, while nimodipine and nifedipine were almost undetectable or undet
ectable, respectively. Lacidipine, at any concentration, determined a dose-
dependent significant decrease of the expression of intercellular adhesion
molecule-1 (ICAM-1) ICAM-1, vascular cell adhesion molecule-1 (VCAM-1) VCAM
-1 and E-selectin (P < 0.01), Lercanidipine and amlodipine determined varia
ble decreases of adhesion molecules at the intermediate and highest concent
rations. Nimodipine and nifedipine determined no effect on ICAM-1,VCAM-1 an
d E-selectin. The lowest IC50, i.e. the concentration determining the 50% r
eduction of ICAM-1, VCAM-1 and E-selectin expression was obtained with laci
dipine for all the adhesion molecules considered (P < 0.01),
Conclusions It is concluded that the effect of the DHPs used in this study
on adhesion molecule expression is determined first by their lipophilicity
and then by their intrinsic antioxidant activity. J Hypertens 1999, 17:1837
-1841 (C) Lippincott Williams & Wilkins.